Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Focal Vibration Therapy in Post-stroke Shoulder Pain

NCT: NCT07513753 · NOT_YET_RECRUITING

NCT IDNCT07513753
StatusNOT_YET_RECRUITING
Start Date2026-04-01
Completion2026-12-01

Brief Summary

Hemiplegic Shoulder Pain (HSP) is a common and disabling complication after stroke, negatively affecting upper limb function, participation in rehabilitation, and quality of life. Despite the widespread use of conservative and physical therapies, evidence supporting the efficacy of specific non-invasive neuromodulation techniques remains limited. Focal Vibration Therapy (FVT) is a non-invasive physical modality that delivers localized mechanical vibration to targeted muscles or tendons and may modulate pain, muscle tone, and proprioception through frequency-dependent mechanisms. This randomized controlled trial aims to evaluate the efficacy of a multimodal FVT protocol, in addition to standard rehabilitation, compared with a sham intervention plus standard rehabilitation, in reducing pain in patients with chronic post-stroke Hemiplegic Shoulder Pain.

Frequently Asked Questions

What is Focal Vibration Therapy in Post-stroke Shoulder Pain?

Focal Vibration Therapy in Post-stroke Shoulder Pain is a clinical trial registered under NCT07513753. Current status: NOT_YET_RECRUITING.

What is the status of NCT07513753?

The current status of NCT07513753 (Focal Vibration Therapy in Post-stroke Shoulder Pain) is: NOT_YET_RECRUITING.

When did Focal Vibration Therapy in Post-stroke Shoulder Pain start?

Focal Vibration Therapy in Post-stroke Shoulder Pain started on 2026-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.